학술논문
The survival benefit of adjuvant trastuzumab with or without chemotherapy in the management of small (T1mic, T1a, T1b, T1c), node negative HER2+ breast cancer.
Document Type
Article
Author
Source
NPJ Breast Cancer; 6/19/2024, Vol. 10 Issue 1, p1-8, 8p
Subject
Language
ISSN
23744677